Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Reviva Pharmaceuticals Holdings, Inc.
Company profile

Reviva Pharmaceuticals Holdings, Inc.

OTC: RVPH · Healthcare · Biotechnology
PublicHQ Cupertino, CA · Santa ClaraCIK 0001742927Reports USD
#1 of 1,394 Healthcare companies by revenue
EA Score
——
FH 28DQ —GM —SS 31
v0.1 · 35/100 weight · pillars only
↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, return on equity
Methodology →
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$19.9M
Employees
14
Market cap
$2.3M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Net income-$19.9M-$19.9M2025
Operating income-$20.2M-$20.2M2025
Total assets$15.9M$15.9M2025
Liabilities$7.3M$7.3M2025
Equity$8.6M$8.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Reviva Pharmaceuticals Holdings, Inc. earned -$19.9M in FY2025 net income.

Peers · Healthcare
INVO Fertility, Inc.43DTrees Corporation——LFTD Partners Inc.45DPMGC Holdings Inc.28D
Neighbors
Santa Clara →
NVIDIA Corporation$215.9B90AApple Inc.$416.2B84B+Alphabet Inc.$402.8B81B+Broadcom Inc.$63.9B75B+Advanced Micro Devices, Inc.$34.6B77B+Intel Corp.$52.9B74B
Key facts
CEOLaxminarayan Bhat
SectorHealthcare
IndustryBiotechnology
HeadquartersCupertino, CA
ExchangeOTC: RVPH
Employees14
IPO date2020-12-15
Latest filings
10-Q2026-05-138-K2026-05-138-K2026-05-138-K2026-04-158-K2026-03-3010-K2026-03-308-K2026-03-198-K2026-03-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies